Director

Jurgen has around 20 years of healthcare experience working for multinational pharma companies, Merck and Mundipharma, as well as MedTech companies such as Epilog. Currently, Jurgen is the director of Kreivo Health, which he founded in 2017, and leads the growth and scaling of Epilog.

As part of his career, Jurgen has launched several products from scratch, developed commercial and development strategies to helped diversify company portfolios, and developed plans for pipeline assets to ensure quick market access and proper pricing. In particular, he was Commercial Director of Mundipharma Singapore, part of which he managed a product portfolio worth USD 500 million. Following this, he was promoted to lead Mundipharma Taiwan and successfully ensured reimbursement of key products, and increased the productivity of the organization by 20%.

Leveraging his experience in the pharmaceutical industry, Jurgen has also supported several healthcare companies in their regional and vertical expansion.

Non Executive Director & Scientific Advisor

Dr Yacine Hadjiat holds a medical degree with a specialization in Pain Management, as well as an MBA in Healthcare Management. He has also completed several trainings and specializations in cancer care, clinical research, health economics, public health & health policy, and technology in healthcare.

Throughout his career, he has held several global senior executive leadership positions in the life-science industry such as Chief Medical Officer, General Manager, and Global Head of Digital Health Solutions based across Europe, US, MEA, and Asia.

Along with his career in the Life Science industry, Dr Hadjiat has several years of clinical practice and clinical research experience, has held advisory and board roles for governmental agencies, startups, and VCs, and has also been deeply engaged in Innovation and Digital health education and research in both Medical Universities and Business Schools.

Executive Project Manager

Ernestine has around 7 years of experience in the pharmaceutical industry of which 5 years were spent in the Medical Communications space working closely with top pharmaceutical companies supporting the development and implementation of their medico-marketing and publication strategies.

Following this, Ernestine served as Regional Medical Affairs Manager for Mundipharma’s Asia Pacific, Middle East, Africa and Latin America (APAC-MEA-LAM) region. Here, she was responsible for the development and implementation of regional medico-marketing strategies and initiatives and successfully expanded the company’s scientific footprint, and strengthened the portfolio value proposition. In her role, she also provided medical evaluation of potential molecules, device and digital solutions for acquisition, co-marketing or in-licensing for portfolio expansion. During this time, she also successfully supported negotiations in Asia Pacific for big distribution/promotion deals with other MNCs.

In 2020, Ernestine joined Kreivo Health as an Executive Project Manager where she currently supports the establishment and expansion of healthcare companies in Asia Pacific and other parts of the world.

Project Manager

Vesper has about 7 years of experience in healthcare industry, 5 of which have been focused on sales and marketing covering pharmaceutical and healthcare companies, while mapping and working closely with local KOLs as well as identifying quick market access.

Throughout working at Mundipharma and MSD in Asia, Vesper has not only delivered significant growth in figures, but also identified breakthrough opportunities in the markets together with launching strategic marketing initiatives to boost long-term sustainable growth. Following this, she supported healthcare and medical device companies across Europe and Asia for prioritizing high-potential markets for entry, building Go-To-Market strategies and capabilities by following the required regulatory procedures. In addition, she has successfully matched local business partners, engaging both parties, and creating a win-win long-term partnership, which further expanded the company’s international presence with her business development capability.

Regulatory and Scientific Affairs Lead

Severine is a Doctor of Pharmacy with a master’s degree in Regulatory Affairs. She has also completed post-graduate diplomas in pharmacovigilance and pharmacoepidemiology, and in immunology.

Severine has around 15 years of experience working in regulatory affairs in several MNCs, across Europe and Asia, covering the entire product lifecycle, from the development phase to post-approval activities, for small molecules as well as biologics. During this time, she held various roles at national, regional and global level, conducting multiple submissions and defining insightful regulatory strategies. As part of her regulatory career, she successfully supported the registration and subsequent launch of a first-in-class product, managed a full manufacture and license transfer and led a major conformance project up to completion.

Severine also worked as a clinical assessor at the French National Agency for the Safety of Medicines and Health Products (ANSM), where she had the opportunity to act as a national appointed expert at a CMDh meeting.

MEA Lead

Hamza has 17 years experience in commercial leadership, marketing, and operations within the pharmaceutical industry. His career journey boasts significant contributions to big and mid-size pharmaceutical organizations, alongside ventures into biotechnology, medical devices, and OTC sectors. Hamza's expertise extends to both establishing companies from the ground up and driving impactful transformations across diverse markets and business models.